Vignola Mark J.
- SEC CIK
- 0001775429
No open-market purchases or sales filed in the past year.
Current role at each company
- TERN Terns Pharmaceuticals, Inc.Chief Financial Officeras of Jan 6, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Vignola Mark J. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 6, 2025 (view filing) | Jan 2-6 | 4 days | Vignola Mark J.Chief Financial Officer | SSale | −17.2K | $5.76 | −$99.0K | −18.7%74.8K after | 2 lots10b5-1 |
| Sep 12, 2024 (view filing) | Sep 10 | 2 days | Vignola Mark J.Chief Financial Officer | SSale | −10.0K | $11.00 | −$110.0K | −9.8%91.9K after | 10b5-1 |
| Jun 4, 2024 (view filing) | May 31 | 4 days | Vignola Mark J.Chief Financial Officer | PPurchase | +4.79K | $4.44 | +$21.3K | +5.5%91.9K after | |
| Dec 4, 2023 (view filing) | Nov 30 | 4 days | Vignola Mark J.Chief Financial Officer | PPurchase | +743 | $3.78 | +$2.81K | +4.2%18.4K after | |
| Jun 2, 2023 (view filing) | May 31 | 2 days | Vignola Mark J.Chief Financial Officer | PPurchase | +10.0K | $1.41 | +$14.1K | +130.5%17.7K after | |
| Feb 3, 2023 (view filing) | Nov 30, 2022 | 65 daysLate | Vignola Mark J.Chief Financial Officer | PPurchase | +3 | $1.41 | +$4.23 | 0.0%7.66K after | |
| Jun 8, 2022 (view filing) | May 31 | 8 daysLate | Vignola Mark J.Chief Financial Officer | PPurchase | +7.66K | $1.47 | +$11.3K | New position7.66K after |